Biomm AAQS

Co robi Biomm? Biomm SA, listed under the ticker BIOM3.SA with ISIN BRBIOMACNOR2, is a biotechnology company headquartered in Nova Lima, Brazil. The company went public on September 5, 2002. Biomm SA focuses on the research, development, and manufacturing of insulin, as well as the development and licensing of technology for producing human insulin and other recombinant proteins. Its technology is designed for the production of therapeutic proteins used in pharmaceutical and biopharmaceutical applications. The company holds patents protecting its insulin production technology across multiple regions, including Europe, Asia, North America, and South America. Biomm SA also engages in the development of production processes for enzymes used in biomass hydrolysis and biofuel manufacturing. As of December 31, 2011, the company operated through subsidiaries Biomm International Inc, Biomm Middle East Inc, and Biomm Russia Ltd. The company's website is https://biomm.com/. Biomm jest jedną z najpopularniejszych firm na Eulerpool.